---
schema_version: "secwatch.filing_event.v1"
accession: "0000856982-23-000066"
form_type: "8-K"
ticker: "MMSI"
cik: "0000856982"
company_name: "MERIT MEDICAL SYSTEMS INC"
filed_at: "2023-12-08T23:59:59+00:00"
generated_at: "2026-06-07T15:55:15.857413+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Merit Medical closes $747.5M convertible note offering at 3.00%, due 2029

## Summary
- Issued $747.5M aggregate principal of 3.00% Convertible Senior Notes due February 1, 2029.
- Net proceeds estimated at $725.1M after discounts; capped call cost ~$66.5M.
- Initial conversion price ~$86.83 per share; conversion rate 11.5171 shares per $1,000 principal.
- Proceeds intended for general corporate purposes including debt reduction, R&D, and potential M&A.
- Capped call transactions entered to reduce dilution upon conversion, with cap price ~$114.68.

## SEC filing metadata
- accession: 0000856982-23-000066
- form_type: 8-K
- ticker: MMSI
- cik: 0000856982
- company_name: MERIT MEDICAL SYSTEMS INC
- filed_at: 2023-12-08T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856982/000085698223000066/0000856982-23-000066-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856982/000085698223000066/mmsi-20231208x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000856982-23-000066
- JSON: https://secwatch.observer/filing/0000856982-23-000066.json
- Plain text: https://secwatch.observer/filing/0000856982-23-000066.txt

## Key facts
- Debt Financings
  MERIT MEDICAL SYSTEMS INC incurred convertible notes of $747.5 million with U.S. Bank Trust Company, National Association at 3.00% maturing February 1, 2029.
  - Instrument: convertible notes
  - Principal: $747.5 million
  - Counterparty: U.S. Bank Trust Company, National Association
  - Rate: 3.00%
  - Maturity: February 1, 2029
  - Event: incurrence
  source text: On December 8, 2023, Merit Medical Systems, Inc. (“Merit”) closed an offering of $747.5 million aggregate principal amount of its 3.00% Convertible Senior Notes due 2029
  evidence_url: https://www.sec.gov/Archives/edgar/data/856982/000085698223000066/0000856982-23-000066-index.htm
- Material Agreements
  MERIT MEDICAL SYSTEMS INC entered into Base Capped Call Transactions with certain of the initial purchasers and/or their respective affiliates and certain other financial institutions (effective 2023-12-05).
  - Action: entry
  - Counterparty: certain of the initial purchasers and/or their respective affiliates and certain other financial institutions
  - Effective: 2023-12-05
  source text: On December 5, 2023, in connection with the pricing of the Notes, Merit entered into privately negotiated capped call transactions (the “Base Capped Call Transactions”) with certain of the initial purchasers and/or their respective affiliates and certain other financial institutions (the “Option Counterparties”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/856982/000085698223000066/0000856982-23-000066-index.htm
- Material Agreements
  MERIT MEDICAL SYSTEMS INC entered into Indenture with U.S. Bank Trust Company, National Association valued at $747.5 million aggregate principal amount (effective 2023-12-08).
  - Action: entry
  - Agreement: notes offering
  - Counterparty: U.S. Bank Trust Company, National Association
  - Value: $747.5 million aggregate principal amount
  - Effective: 2023-12-08
  source text: On December 8, 2023, Merit Medical Systems, Inc. (“Merit”) closed an offering of $747.5 million aggregate principal amount of its 3.00% Convertible Senior Notes due 2029 (the “Notes”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/856982/000085698223000066/0000856982-23-000066-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.